For what patients are you adopting the PROSPECT approach into your rectal cancer practice?
How are you approaching patients with rectal cancer who meet PROSPECT criteria but have other higher risk features, such as >4 lymph nodes with suspicious features (but <1 cm)?
Answer from: Radiation Oncologist at Academic Institution
Yes, the results of the trial are certainly factored into a multidisciplinary discussion. It is important to have a multidisciplinary discussion and to have shared decision-making with the patients. We often incorporate response to FOLFOX in this setting to decide. Although it is very subjective, we...
Sign in or Register to read more